Screener
Haemonetics HAE Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Haemonetics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 6:09 AM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0000313143-26-000120
FAQ
- What is Haemonetics's total equity?
- Haemonetics (HAE) reported total equity of $837.1M in Q2 2026.
- How has Haemonetics's total equity changed year-over-year?
- Haemonetics's total equity decreased by 5.1% year-over-year, from $882.3M to $837.1M.
- What is the long-term trend for Haemonetics's total equity?
- Over 5 years (2021 to 2026), Haemonetics's total equity has grown at a 1.7% compound annual growth rate (CAGR), from $731.67M to $796.32M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Haemonetics's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude